Latest Bevacizumab Stories

2013-04-25 23:01:50

Preventive medicine may not be the panacea to reducing healthcare costs. Ponte Vedra Beach, Florida (PRWEB) April 25, 2013 This week´s top news story on HealthEconomics.Com related to yet another rejection by the National Institute for Health and Care Excellence (NICE) for Roche´s Avastin (bevacizumab) for advanced ovarian cancer. NICE is the agency tasked with appraising cost-effectiveness of medicines for use in the National Health Service for England and Wales. Issuing its...

2013-04-22 11:22:53

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma. In a paper published in the April 19 issue of Molecular Cancer Therapeutics, a team led by Nancy Klauber-DeMore, MD, professor of surgery and a member of UNC Lineberger Comprehensive Cancer Center, used a monoclonal antibody to target SFRP2 expressed in cells from triple-negative breast...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.